Skip to content

Clinical trials

Phase 1 Colonic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Phase 1 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20192
20201
20212
20223
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Unknown status4
Active, not recruiting1
Completed1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd3
Beijing Friendship Hospital1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Fudan University1
GONGCHU Biotechnology Co., Ltd1
Jiujiang University Affiliated Hospital1
Novartis Pharmaceuticals1
Second Affiliated Hospital of Guangzhou Medical University1
Sichuan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms13
Lung Neoplasms6
Stomach Neoplasms6
Breast Neoplasms4
Carcinoma, Hepatocellular4
Esophageal Neoplasms4
Pancreatic Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Rectal Neoplasms3
Cholangiocarcinoma2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.